878 related articles for article (PubMed ID: 19655809)
1. Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations.
Lennernäs H
Mol Pharm; 2009; 6(5):1429-40. PubMed ID: 19655809
[TBL] [Abstract][Full Text] [Related]
2. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption.
Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB
J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231
[TBL] [Abstract][Full Text] [Related]
3. Effects of erythromycin on gastric emptying, alcohol absorption and small intestinal transit in normal subjects.
Edelbroek MA; Horowitz M; Wishart JM; Akkermans LM
J Nucl Med; 1993 Apr; 34(4):582-8. PubMed ID: 8455074
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
Kortejärvi H; Urtti A; Yliperttula M
Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
[TBL] [Abstract][Full Text] [Related]
5. Interaction of prandial state and beverage concentration on alcohol absorption.
Roine R
Alcohol Clin Exp Res; 2000 Apr; 24(4):411-2. PubMed ID: 10798569
[No Abstract] [Full Text] [Related]
6. Behaviour and transit of tamsulosin Oral Controlled Absorption System in the gastrointestinal tract.
Stevens HN; Speakman M
Curr Med Res Opin; 2006 Dec; 22(12):2323-8. PubMed ID: 17257446
[TBL] [Abstract][Full Text] [Related]
7. The effect of ethanol and alcoholic beverages on gastric emptying of solid meals in humans.
Franke A; Nakchbandi IA; Schneider A; Harder H; Singer MV
Alcohol Alcohol; 2005; 40(3):187-93. PubMed ID: 15699055
[TBL] [Abstract][Full Text] [Related]
8. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
[TBL] [Abstract][Full Text] [Related]
9. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
Kuentz M; Nick S; Parrott N; Röthlisberger D
Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo simulation of an ethanol pharmacokinetic model.
Whitmire D; Cornelius L; Whitmire P
Alcohol Clin Exp Res; 2002 Oct; 26(10):1484-93. PubMed ID: 12394281
[TBL] [Abstract][Full Text] [Related]
11. The influence of gastric emptying kinetics on the drug release from enteric coated pellets in fasted state: an in vitro/in vivo correlation.
Stefanič M; Locatelli I; Vrečer F; Sever T; Mrhar A; Bogataj M
Eur J Pharm Biopharm; 2012 Oct; 82(2):376-82. PubMed ID: 22884655
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic understanding of time-dependent oral absorption based on gastric motor activity in humans.
Higaki K; Choe SY; Löbenberg R; Welage LS; Amidon GL
Eur J Pharm Biopharm; 2008 Sep; 70(1):313-25. PubMed ID: 18434110
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal dynamics and pharmacology for the optimum design of controlled-release oral dosage forms.
Read NW; Sugden K
Crit Rev Ther Drug Carrier Syst; 1988; 4(3):221-63. PubMed ID: 3276406
[TBL] [Abstract][Full Text] [Related]
14. Impact of the intragastric location of extended release tablets on food interactions.
Weitschies W; Wedemeyer RS; Kosch O; Fach K; Nagel S; Söderlind E; Trahms L; Abrahamsson B; Mönnikes H
J Control Release; 2005 Nov; 108(2-3):375-85. PubMed ID: 16213057
[TBL] [Abstract][Full Text] [Related]
15. The delayed dissolution of paracetamol products in the canine fed stomach can be predicted in vitro but it does not affect the onset of plasma levels.
Kalantzi L; Polentarutti B; Albery T; Laitmer D; Abrahamsson B; Dressman J; Reppas C
Int J Pharm; 2005 May; 296(1-2):87-93. PubMed ID: 15885459
[TBL] [Abstract][Full Text] [Related]
16. The design of controlled-release formulations resistant to alcohol-induced dose dumping--a review.
Jedinger N; Khinast J; Roblegg E
Eur J Pharm Biopharm; 2014 Jul; 87(2):217-26. PubMed ID: 24613542
[TBL] [Abstract][Full Text] [Related]
17. Sluggish gallbladder emptying and gastrointestinal transit after intake of common alcoholic beverages.
Kasicka-Jonderko A; Jonderko K; Gajek E; Piekielniak A; Zawislan R
J Physiol Pharmacol; 2014 Feb; 65(1):55-66. PubMed ID: 24622830
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug.
Fujioka Y; Metsugi Y; Ogawara K; Higaki K; Kimura T
Int J Pharm; 2008 Mar; 352(1-2):36-43. PubMed ID: 18037251
[TBL] [Abstract][Full Text] [Related]
19. Effect of ethanol on the release of morphine sulfate from Oramorph SR tablets.
Barkin RL; Shirazi D; Kinzler E
Am J Ther; 2009; 16(6):482-6. PubMed ID: 19770796
[TBL] [Abstract][Full Text] [Related]
20. Companion animal physiology and dosage form performance.
Sutton SC
Adv Drug Deliv Rev; 2004 Jun; 56(10):1383-98. PubMed ID: 15191788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
